CDMO News
EnWave Signs Agreement with BioTechnique to Explore REV Technology for Biopharma
EnWave Corporation has entered into a master service agreement with BioTechnique, a U.S.-based pharmaceutical contract manufacturing organisation (CDMO). The agreement sets the framework for BioTechnique to assess EnWave’s Radiant Energy Vacuum (REV) dehydration technology as a potential alternative to traditional lyophilization
31 March 2025